Skip to content
Kalpvruksh Markets
Offline Log in

BIOCONNSEOffline

BIOCON · INE376G01013 · Mid Cap · #175
362.00+17.55 (+5.10%)last close · 05 Nov 2026
Prev close
344.45
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹60,927 cr
52-week range · to 05 Nov 2026323.5440.7

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

BIOCON is 18% below its 52-week high, below its 200-day average, behind Healthcare by 15.6 pts over 3 months — a Mid Cap company, #175 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20-day average · below its 50 / 200-day averages · 18% below its 52-week high
  • behind its industry by 15.6 pts over 3 months · rank 41 of 44 in Healthcare · −13.0% vs Nifty 500
  • traded value 1.6× usual · delivery 37% vs 51% usual
  • short covering today (2 sessions running) · IV 26%, 27th pct of its year · expected move ±5.8% to expiry
  • FPI +0.5 pp · DII +5.9 pp · MF schemes in Sept 2026: 63 bought, 59 cut · no promoter pledge · quarter ended 2026-09-30
  • Jun 2026 quarter: profit +349% year on year · revenue +10%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹60,927 cr
Rank
#175
Cap band
Mid Cap
Nearest cut-off — Large / Mid
−42.75% from ₹1,06,417 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.7×
median 15,95,511
Delivered
27,89,713
Of volume
38%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+2.9%−2.8 pts—
1 month−1.9%−6.2 pts−5.6 pts
3 months−14.9%−13.0 pts−15.6 pts
6 months−4.9%−5.3 pts−14.2 pts
1 year−3.9%−1.3 pts—

Industry: Healthcare (Nifty 500 classification) · rank 41 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+5.0%
above
vs 50-day average
−2.7%
below
vs 200-day average
−7.2%
below
ATR (14)
3.1%
typical daily range
Volatility
35%
1 month, annualised
Beta
0.76
vs Nifty 500, 1 year
Traded value
1.6×
vs usual
Delivery
37%
usual 51%
From the 52-week high
−17.9%
place in range 33% (0 = at the low)

F&O

Where option open interest clusters

expiry 23 Nov 2026 · 18 days

Spot
362
Max pain
340
−6.1% from spot
Largest call OI (strike)
Largest put OI (strike)

Near expiry. Max pain is the strike at which option buyers’ total payout would be least; strikes with the most open interest are where positions cluster.

Volatility & expected move

ATM IV
26.3%
near expiry
IV 30
26.3%
IV rank
29
0–100 within its year
IV percentile
27
days in the year below today
Expected move to expiry
±21.11
±5.8% · one standard deviation
Range
341 – 383
Rollover
3%
futures OI in next expiries

Futures build-up, by day

all expiries' OI · today: short covering · 2 sessions

SessionBuild-upFuture priceOI, all expiries
05 Nov 2026short covering+5.0%−1.9%
04 Nov 2026short covering+0.7%−3.1%
03 Nov 2026short build-up−3.3%+2.6%
02 Nov 2026short covering+0.7%−0.7%
30 Oct 2026long unwinding−0.1%−0.4%
29 Oct 2026short covering+0.6%−0.1%
28 Oct 2026long build-up+4.7%+0.9%
27 Oct 2026long build-up+1.4%+2.1%
26 Oct 2026long build-up+1.7%+7.8%
23 Oct 2026long unwinding−2.3%−1.5%

From the exchanges’ F&O bhavcopies. A description of positions, not a forecast. Open interest across the market.

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters54.5%44.9% −9.544.7% −0.244.7%
FPI7.4%7.5% +0.18.1% +0.68.6% +0.5
Mutual funds13.8%16.5% +2.815.5% −1.122.1% +6.6
Other DII7.9%7.5% −0.47.9% +0.47.1% −0.7
Individuals12.4%10.0% −2.410.3% +0.310.2% −0.1
Others4.1%13.6% +9.513.6%7.3% −6.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
3,93,051
Individuals
3,74,795

Indian passive funds’ stake

2026-06-30

Of free float
0.77%
Of all shares
0.43%
Schemes
75
Days to unwind
2.0
at 100% of volume

69,53,265 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
190
75 index · 115 active
Bought more
92
Sold some
31
FundSharesChangeDid
Kotak Balanced Advantage Fund-Reg(G)Active+4,71,698+1572.3%bought
ICICI Pru Equity Savings Fund-Reg(G)Active+5,87,500+940.0%bought
Edelweiss Arbitrage Fund-Reg(G)Active+4,95,000+825.0%bought
Nippon India Multi Cap Fund(G)Active−43,66,606−86.9%sold
Kotak ESG Exclusionary Strategy Fund-Reg(G)Active−1,80,000−66.7%sold
ICICI Pru Innovation Fund-Reg(G)Active−18,36,596−66.6%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26183657545+7.1%₹11,042 cr
Aug 2618217841622+0.4%₹11,473 cr
Jul 261874069417+28.3%₹11,810 cr
Jun 261541057315−5.0%₹9,046 cr
May 261491262247−4.3%₹9,757 cr
Apr 26144865205−1.2%₹8,553 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 0 of 53 disclosures

None in the latest 50 disclosures — switch to Everyone.

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Biocon Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    04 Nov 2026
  • Board outcome
    Biocon Limited has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026.
    04 Nov 2026
  • Board outcome
    Biocon Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    06 Aug 2026
  • Takeover (SAST)
    Mylan Inc. has Submitted to the Exchange a copy of Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
    15 Jul 2026
  • Scheme / acquisition
    Biocon Limited has informed the Exchange about Acquisition
    30 Jun 2026
  • Scheme / acquisition
    Biocon Limited has informed the Exchange about Acquisition
    11 Jun 2026
  • Bulk deal: BUY
    1,84,37,500 at ₹400 — ICICI PRUDENTIAL MUTUAL FUND
    14 Jul 2026
  • Bulk deal: SELL
    4,59,83,509 at ₹400 — MYLAN INC.
    14 Jul 2026
  • Block deal: BUY
    6,26,000 at ₹400 — 360 ONE MUTUAL FUND
    14 Jul 2026
  • Block deal: BUY
    12,50,000 at ₹400 — ADITYA BIRLA SUNLIFE MUTUAL FUND
    14 Jul 2026

Latest shown; 11 in six months on all disclosures.

BIOCON: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹0.5Final03 Jul 202603 Jul 2026
EarlierDividend₹0.5Final04 Jul 202504 Jul 2025
EarlierDividend₹0.5Final05 Jul 202405 Jul 2024
EarlierDividend₹1.5Final07 Jul 202307 Jul 2023
EarlierDividend₹0.5Final30 Jun 202201 Jul 2022
EarlierBonus1:1—12 Jun 201913 Jun 2019
EarlierBonus2:1—15 Jun 201717 Jun 2017
EarlierBonus1:1—11 Sept 200812 Sept 2008

8 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.